Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Ghassan K. Abou‐Alfa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1522-8054; OpenAlex author ID A5081273660. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
0
Collaborators
48
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 3 papers · 2014: 1 paper · 2015: none · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 13

  1. Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort. Co-author DOI 10.1093/jnci/djae269↗
  2. Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer. Co-author DOI 10.1002/cncr.34269↗
  3. Neo-adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma. Co-author DOI 10.1111/ajco.13775↗
  4. Brain Metastases in Pancreatic Ductal Adenocarcinoma: Assessment of Molecular Genotype-Phenotype Features-An Entity With an Increasing Incidence? Co-author DOI 10.1016/j.clcc.2018.01.009↗
  5. A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1002/cncr.30897↗
  6. Real-Time Genomic Profiling of Pancreatic Ductal Adenocarcinoma: Potential Actionability and Correlation with Clinical Phenotype. Co-author DOI 10.1158/1078-0432.ccr-17-0899↗
  7. Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-14-0531↗
  8. Management of a patient diagnosed with pancreatic cancer and myelodysplastic syndrome. Last author PMID 23745160↗
  9. Optimal chemotherapy dosing in a bilateral lower extremities amputee with metastatic pancreatic adenocarcinoma. Last author PMID 23936551↗
  10. Modified GTX as Second-Line Chemotherapy in Advanced Pancreatic Cancer. Last author PMID 24147159↗
  11. Communication and palliative care in a 64-year-old man with pancreatic adenocarcinoma. First author PMID 23077687↗
  12. Neoadjuvant Therapy in Clinical Stage II Pancreatic Adenocarcinoma. Co-author PMID 23112885↗
  13. Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine. Co-author DOI 10.1097/coc.0b013e3181e84b1f↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eileen Mary O'Reilly · 13 shared papers, 2011–2025 · strength 0.84
  2. Kenneth H. Yu · 7 shared papers, 2013–2025 · strength 0.54
  3. David Paul Kelsen · 6 shared papers, 2011–2025 · strength 0.43
  4. Marinela Capanu · 4 shared papers, 2011–2025 · strength 0.37
  5. Anna M. Varghese · 3 shared papers, 2017–2025 · strength 0.34
  6. Wungki Park · 2 shared papers, 2022–2025 · strength 0.29
  7. Ali I. Shamseddine · 5 shared papers, 2012–2022 · strength 0.26
  8. Maeve Aine Lowery · 5 shared papers, 2012–2018 · strength 0.25
  9. Vinod P. Balachandran · 2 shared papers, 2017–2025 · strength 0.22
  10. William R. Jarnagin · 2 shared papers, 2017–2025 · strength 0.22
  11. Sally Naji Temraz · 3 shared papers, 2012–2022 · strength 0.20
  12. Leonard B. Saltz · 5 shared papers, 2012–2017 · strength 0.18
  13. Haifa Dbouk · 2 shared papers, 2013–2022 · strength 0.17
  14. Fergus Keane · 1 shared paper, 2025 · strength 0.17
  15. Fionnuala Crowley · 1 shared paper, 2025 · strength 0.17
  16. Kevin C. Soares · 1 shared paper, 2025 · strength 0.17
  17. Darren Cowzer · 1 shared paper, 2025 · strength 0.17
  18. T. Peter Kingham · 1 shared paper, 2025 · strength 0.17
  19. Michael Ian D'Angelica · 1 shared paper, 2025 · strength 0.17
  20. Jeffrey A. Drebin · 1 shared paper, 2025 · strength 0.17
  21. Anupriya Singhal · 1 shared paper, 2025 · strength 0.17
  22. Fiyinfolu O. Balogun · 1 shared paper, 2025 · strength 0.17
  23. Christopher H. Crane · 1 shared paper, 2025 · strength 0.17
  24. Alice Chia-Chi Wei · 1 shared paper, 2025 · strength 0.17
  25. Walid Ghazi Faraj · 2 shared papers, 2012–2022 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.